Related Experiment Video
Updated: Jan 24, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Rivaroxaban in atrial fibrillation cardioversion: an update
Carlo Lavalle1, Martina Straito1, Annalisa Caroli1
1Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, "Sapienza" University of Rome, Policlinico Umberto I, Rome, Italy.
Rivaroxaban is effective and safe for patients with atrial fibrillation (AF) undergoing cardioversion, offering a better alternative to vitamin K antagonists. This approach reduces embolic events and improves patient satisfaction while managing costs.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Atrial fibrillation (AF) is a common arrhythmia, increasing stroke and thromboembolism risk.
- Effective anticoagulation is crucial for cardioversion, but vitamin K antagonists often have suboptimal outcomes.
- Novel oral anticoagulants offer potential advantages in AF management.
Purpose of the Study:
- To review evidence on rivaroxaban's efficacy and safety in non-valvular AF patients undergoing cardioversion.
- To discuss real-world data supporting rivaroxaban use in this clinical setting.
- To explore rivaroxaban's role in left atrial appendage thrombi resolution.
Main Methods:
- Review of major randomized controlled trials (RCTs) on rivaroxaban for AF cardioversion.
- Analysis of real-world studies documenting rivaroxaban use in clinical practice.
- Discussion of existing data on novel oral anticoagulants in AF thrombi resolution.
Main Results:
- Rivaroxaban demonstrates effectiveness and safety in AF patients undergoing cardioversion.
- Studies indicate rivaroxaban avoids additional health costs and time loss.
- Patient satisfaction is improved with rivaroxaban treatment.
Conclusions:
- Rivaroxaban is a viable and effective anticoagulation strategy for AF cardioversion.
- Its use in clinical practice is supported by robust trial and real-world data.
- Further research is needed on novel oral anticoagulants for left atrial appendage thrombi resolution.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Schemas
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...

